Annual Total Debt
$450.60 K
+$450.60 K+100.00%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual total debt is $450.60 thousand, with the most recent change of +$450.60 thousand (+100.00%) on December 1, 2023.
- During the last 3 years, RNAZ annual total debt has fallen by -$1.64 million (-78.41%).
- RNAZ annual total debt is now -78.41% below its all-time high of $2.09 million, reached on December 31, 2020.
Performance
RNAZ Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$152.50 K
-$74.70 K-32.88%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly total debt is $152.50 thousand, with the most recent change of -$74.70 thousand (-32.88%) on September 1, 2024.
- Over the past year, RNAZ quarterly total debt has dropped by -$442.20 thousand (-74.36%).
- RNAZ quarterly total debt is now -92.83% below its all-time high of $2.13 million, reached on June 30, 2021.
Performance
RNAZ Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
RNAZ Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | -74.4% |
| 3 y3 years | -78.4% | +100.0% |
| 5 y5 years | -51.4% | +100.0% |
RNAZ Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -80.2% | -100.0% |
| 5 y | 5-year | -78.4% | -100.0% | -92.8% | -100.0% |
| alltime | all time | -78.4% | -100.0% | -92.8% | -100.0% |
TransCode Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $152.50 K(-32.9%) |
| Jun 2024 | - | $227.20 K(-33.1%) |
| Mar 2024 | - | $339.40 K(-24.7%) |
| Dec 2023 | $450.60 K(>+9900.0%) | $450.60 K(-24.2%) |
| Sep 2023 | - | $594.70 K(-10.3%) |
| Jun 2023 | - | $663.30 K(-13.7%) |
| Mar 2023 | - | $768.20 K(>+9900.0%) |
| Dec 2022 | $0.00 | $0.00(0.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(-100.0%) |
| Jun 2021 | - | $2.13 M(+0.9%) |
| Mar 2021 | - | $2.11 M(+0.9%) |
| Dec 2020 | $2.09 M(+124.9%) | - |
| Dec 2020 | - | $2.09 M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00 |
| Dec 2019 | $927.80 K | - |
FAQ
- What is TransCode Therapeutics annual total debt?
- What is the all time high annual total debt for TransCode Therapeutics?
- What is TransCode Therapeutics annual total debt year-on-year change?
- What is TransCode Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly total debt year-on-year change?
What is TransCode Therapeutics annual total debt?
The current annual total debt of RNAZ is $450.60 K
What is the all time high annual total debt for TransCode Therapeutics?
TransCode Therapeutics all-time high annual total debt is $2.09 M
What is TransCode Therapeutics annual total debt year-on-year change?
Over the past year, RNAZ annual total debt has changed by +$450.60 K (+100.00%)
What is TransCode Therapeutics quarterly total debt?
The current quarterly total debt of RNAZ is $152.50 K
What is the all time high quarterly total debt for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly total debt is $2.13 M
What is TransCode Therapeutics quarterly total debt year-on-year change?
Over the past year, RNAZ quarterly total debt has changed by -$442.20 K (-74.36%)